We are pleased to share an updated compendium of clinical experience involving Low-Intensity Shock Wave Therapy (LISWT) using the MORENOVA® device. This document provides an aggregated overview of patient outcomes across several treatment settings, offering valuable insights into the clinical utility of LISWT as a regenerative treatment for erectile dysfunction (ED). The compendium includes results from multiple clinics treating men with varying degrees of ED — often in the presence of comorbidities such as hypertension, diabetes, and post-prostatectomy complications. MORENOVA® is used to deliver focused shockwaves to the penile tissue to stimulate neovascularization and improve blood flow, offering a non-invasive, drug-free approach to treatment. Across these clinical environments, patients underwent a standardized course of five LISWT sessions, administered over 2–5 weeks. Outcomes were assessed using validated tools such as: Efficacy Patient Profile Tolerability and Compliance About the MORENOVA® Device MORENOVA® is a compact shockwave therapy system designed to deliver 1,800 focused waves per session using linear applicator technology. Developed by DIREX Group, the system is engineered for comfort, convenience, and clinical flexibility. Its applications are particularly beneficial for patients who: Download the full PDF >> https://direxgroup.com/wp-content/uploads/2025/06/Compendium_ED_pagenumber.pdf